News
1mon
GlobalData on MSNElixirgen’s gene therapy shows promise in telomere biology disordersEXG-34217 is described as a dose of autologous CD34+ haematopoietic stem cells containing ... which can lead to bone marrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results